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Abstract
Background: The symptoms of numerous diseases result from genetic mutations that disrupt the homeostasis maintained
by the appropriate integration of signaling gene activities. The relationships between signaling genes suggest avenues
through which homeostasis can be restored and disease symptoms subsequently reduced. Specifically, disease symptoms
caused by loss-of-function mutations in a particular gene may be reduced by concomitant perturbations in genes with
antagonistic activities.
Methodology/Principal Findings: Here we use network-neighborhood analyses to predict genetic interactions in
Caenorhabditis elegans towards mapping antagonisms and synergisms between genes in an animal model. Most of the
predicted interactions are novel, and the experimental validation establishes that our approach provides a gain in accuracy
compared to previous efforts. In particular, we identified genetic interactors of gdi-1, the orthologue of GDI1, a gene associated
with mental retardation in human. Interestingly, some gdi-1 interactors have human orthologues with known neurological
functions, and upon validation of the interactions in mammalian systems, these orthologues would be potential therapeutic
targets for GDI1-associated neurological disorders. We also observed the conservation of a gdi-1 interaction between different
cellular systems in C. elegans, suggesting the involvement of GDI1 in human muscle degeneration.
Conclusions/Significance: We developed a novel predictor of genetic interactions that may have the ability to significantly
streamline the identification of therapeutic targets for monogenic disorders involving genes conserved between human
and C. elegans.
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Introduction
Many biological mechanisms depend on a state of signaling
homeostasis maintained by the appropriate integration of the
synergistic and antagonistic activities of signaling genes [1].
Accordingly, the symptoms of numerous diseases result from
genetic mutations that disrupt this homeostasis [2–5]. The
relationships between signaling genes suggest avenues through
which homeostasis can be restored and disease symptoms
subsequently reduced. Specifically, disruptions caused by loss-of-
function mutations in a particular gene may be compensated by
concomitant perturbations in genes with antagonistic activities.
Antagonisms and synergisms between genes can be identified
via genetic interactions. A genetic interaction between two genes
exists when the phenotypic effect of a perturbation (e.g. mutation,
RNAi treatment, drug targeting) in one gene is dependent upon a
perturbation in the other gene. Thus, disease symptoms caused by
mutations in a given gene may be compensated by perturbing
genetic interactors of the gene. That is, the genetic interactors are
potential therapeutic targets. Therefore, the identification of
genetic interactions is an important step towards the development
of treatments for monogenic disorders.
The nematode Caenorhabditis elegans is an ideal animal model for
identifying genetic interactions due its genetic tractability.
Furthermore, the high degree of conservation of molecular
pathways related to human diseases has facilitated the dissection
of physiopathological mechanisms of genetic disorders including
Duchenne Muscular Dystrophy (DMD; OMIM: 310200), lyso-
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[6–8]. Although the extent to which genetic interactions are
conserved between C. elegans and human is unknown, previous
studies encourage the use of C. elegans towards the identification of
therapeutic targets for human diseases. For example, a genome-
wide RNAi suppressor screen in a C. elegans model of type 2
diabetes, i.e. a strain with a loss-of-function mutation in the C.
elegans insulin-like growth factor receptor daf-2, led to the
identification of a kinase that exhibits antagonistic activity towards
daf-2. Interestingly, mice with the kinase knocked-out appeared to
be protected against diabetes, suggesting that the antagonistic
interaction identified in C. elegans led to the identification of a
potential therapeutic target for a human disease [8]. The
application of systematic screens for other diseases hinges on the
development of high-throughput techniques enabling the quanti-
fication of relevant phenotypes. However, the development of such
quantitative techniques is in general time-consuming and may be
extremely challenging. An alternative approach involves the in
silico prediction of genetic interactions [9–11]. Interestingly, the
rate at which genetic interactions are identified with prediction-
driven screens appears to be significantly greater than the rate for
systematic experimental screens (Figure 1). This suggests that in
silico prediction represents an efficient approach to identifying
genetic interactions.
All existing in silico approaches for predicting genetic interac-
tions use several types of data including gene expression
measurements and protein-protein (PP) interactions.
Lee and colleagues developed a method for predicting whether
two given genes have a shared function [9]. The method is based
on the weighted integration of gene pair data and was trained with
pairs of genes that share functional annotations as positive learning
examples. The predictions can be used in turn to infer genetic
interactions, since pairs of genes that share function tend to exhibit
synergistic interactions. Moreover, known antagonists of a given
gene can be used as so-called seeds to search for other antagonists
of the gene; specifically, genes predicted to share function with the
seeds are inferred to be antagonists as well. However, many genes
that share a function do not synergistically interact with each other
nor do they antagonize the same gene(s), and therefore the
accuracy of this approach for predicting genetic interactions may
be limited (see the validation success rate in Figure 1).
Zhong and Sternberg developed a method to directly predict
genetic interactions [10]. This method is also based on the
weighted integration of gene pair data, but was trained with
known genetic and PP interactions as positive learning examples.
However, the method predicts a set of genetic interactions that
involves only a small portion of all C. elegans genes (,8% of the
genome, see Figure 1). This may be due to the amount of data
specific to a given gene pair that is required to make a prediction,
since such data is scarce for many gene pairs.
Chipman and Singh developed an approach for predicting
synergistic interactions only [11]. This approach uses information
gained from the contexts of genes in a biological network that
integrates several types of data (e.g. an edge exists between two
genes if they encode proteins that exhibit a PP interaction),
specifically by using the proximity between genes in the network.
While this approach appears extremely powerful based on the in
silico validation results, it remains to be determined how well this
approach performs according to experimental validation.
Since all experimentally validated approaches for predicting
genetic interactions currently suffer from limited accuracy or predict
genetic interaction sets with limited genome coverage, we developed
an o v e lin silico approach that uses statistical analyses of gene/protein
neighborhoods in biological networks (Figure 2). Unlike previous
approaches, the prediction of a genetic interaction between two
given genes is aided by analyses that detect common features of the
neighborhoods of the genes, or their encoded proteins (e.g. common
PP interactors of the proteins). Furthermore, our approach does not
require ‘seeds’ for every gene of interest to predict novel antagonistic
interactions, unlike the Lee et al. approach [9], and while our
approach appears comparable to the Zhong and Sternberg
approach [10] in terms of specificity, our set of predicted genetic
interactions has greater genome coverage (Figure 1).
The overall aim of this study was to identify genetic interactions
in C. elegans that warrant further study in mammals towards the
identification of promising therapeutic targets for genetic diseases.
We thus used our approach to identify genetic interactors of the
Rab-specific guanine-nucleotide dissociation inhibitor gdi-1
(WormBase: WBGene00001558) which shares 80% protein
sequence identity with GDI1 (Ensembl: ENSG00000203879; Blast
E-value: 2.10610
2158), a gene associated with non-syndromic
forms of mental retardation in human (OMIM: 300104) [5]. GDI1
encodes GDIa, a major regulator of Rab GTPase activity during
Figure 1. Comparison of large-scale genetic interaction studies
in C. elegans. The studies are compared in terms of the percentage of
genes with identified/predicted interactions and the success rate of
experimental validation (i.e. the fraction of tested gene pairs that exhibit a
genetic interaction). Systematic experimental screens test a limited
number of gene pairs due to the labor-intensive experimental
procedures. Moreover, these screens identify a small number of
interactions relative to the number of tested gene pairs since genetic
interactions appear to be rare. Prediction-based methods can assess all
pairs of genes in silico, and consequently, the percentage of genes with
predicted interactions tends to be larger than the percentage of genes
with interactions identified by a systematic experimental screen.
Moreover, predictions focus experimental efforts on gene pairs that are
likely to exhibit a genetic interaction. Accordingly, the success rates of
prediction-driven screens tend to be greater than the rates for systematic
experimental screens. The success rate of our study shown here is
conservative since it was computed based on the following definition: a
gene pair exhibits an interaction only if the interaction is statistically
significant according to all considered epistasis models (see Methods).
doi:10.1371/journal.pone.0010624.g001
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regulator of cell signaling events. The validation of predicted
genetic interactions of gdi-1 identified several antagonists. If these
genetic interactions are conserved in the relevant human disease
system, they would suggest therapeutic targets for GDI1-associated
cognitive disorders. In addition, our results suggest the conserva-
tion of a subset of genetic interactions across different cellular
systems in C. elegans, and the involvement of GDI1 in human
myopathies resulting from mutations in components of the
Dystrophin Glycoprotein Complex (DGC).
Results
The predictor of genetic interactions in C. elegans
We developed a predictor of genetic interactions using a
learning set that contains positive and negative examples of
interactions from the literature (see Table S1 for the manually-
curated interactions) and gene pairs randomly selected from the C.
elegans genome, respectively (see Methods). Since it is estimated
that the vast majority of gene pairs do not genetically interact [13],
a set of randomly selected gene pairs is expected to be enriched
with true negative examples.
Our predictor uses gene expression measurements, RNAi
knockdown phenotype observations and PP interactions from
multiple species to measure the likelihood of a genetic interaction.
The gene expression measurements were obtained from DNA
microarray results [14], and the phenotype observations were
obtained from genome-wide RNAi experiment results (see
Methods). A multi-species PP interaction network was constructed
with C. elegans, Drosophila melanogaster, Homo sapiens and Saccharomyces
cerevisiae PP interactions identified by yeast two-hybrid (obtained
from BioGRID and [15,16]). PP interactions from species other
than C. elegans were incorporated using InParanoid orthology maps
[17]. For any two given genes, we considered a measure of their
coexpression (Exp), a measure of their phenotype similarity (Ph)
and an indicator of a PP interaction between their encoded
proteins or orthologues (I) as gene pair attributes that might help
determine whether the given genes genetically interact. Variants of
the Exp, Ph and I attributes have been used by existing predictors
of genetic interactions [9,10].
Figure 2. Gene pair attributes used to predict genetic interactions. The two genes/proteins of interest are highlighted with thick grey
rings. (A) I, the presence or absence of a protein-protein (PP) interaction between the proteins encoded by the genes of interest, or their
orthologues. (B) CI, a measure of the significance of the overlap between the PP interaction neighborhoods of the proteins encoded by the genes
of interest (i.e. overlap of the red and blue regions). The PP interaction neighborhood of a given protein is the set of all of proteins that exhibit a PP
interaction with the given protein (according to the multi-species PP interaction network). (C) N, an indicator for whether the neighborhoods of the
genes of interest are enriched with the same phenotype. Here we define the neighborhood of a given gene as the set of genes that show
significant coexpression (P#0.05, see Methods) with the given gene and/or encode proteins that exhibit a PP interaction with the product of the
given gene (according to the multi-species PP interaction network). Both neighborhoods shown here are enriched with a particular phenotype. (D)
NPh, an indicator like N with the additional requirement that the genes of interest themselves must also exhibit the phenotype enriched in their
neighborhoods.
doi:10.1371/journal.pone.0010624.g002
Predicting gdi-1 Interactors
PLoS ONE | www.plosone.org 3 May 2010 | Volume 5 | Issue 5 | e10624Importantly, our approach is the first to use particular features
of biological networks in order to improve the accuracy of the
prediction of genetic interactions. For example, considering the
multi-species PP interaction network, we define the neighborhood
of a protein as the set of proteins that exhibit a PP interaction with
it (possibly via orthology). Although two given proteins may not be
known to exhibit a PP interaction, their neighborhoods may
contain a surprising number of common PP interactors (Figure 2B).
We defined a gene pair attribute based on the encoded proteins of
the two genes of interest, measuring the significance of their
number of common PP interactors (CI). The set of gene pairs that
encode proteins with significantly many common PP interactors
(CI#0.05) is enriched with gene pairs that are known to genetically
interact (P=6.67610
239, hypergeometric test).
We also investigated whether a biological network that
integrates observations of phenotype similarity, coexpression and
PP interaction can improve the prediction of genetic interactions.
We defined a novel biological network called the PhEP network,
where nodes represent genes and the genes are labeled with their
RNAi knockdown phenotypes. Two genes are connected by an
edge if they are significantly coexpressed and/or if they encode or
have orthologous proteins that exhibit a PP interaction (see
Methods). Although a phenotype observation may be absent for
the gene itself, such observations may be available for several of its
neighbors (i.e. the genes connected to the gene of interest by one
edge) in the PhEP network. We therefore defined a gene pair
attribute indicating the enrichment of genes associated with some
phenotype in the neighborhoods of both genes of interest, in the
PhEP network (N, see Figure 2C). We demonstrated that the set of
gene pairs with such neighborhood characteristics is enriched with
gene pairs that are known to genetically interact (P=1.20610
2245,
hypergeometric test). By the same line of reasoning, we defined a
variant of this gene pair attribute, NPh, indicating that the two
genes of interest are annotated with the phenotype that is enriched
in both of their neighborhoods in the PhEP network (see
Figure 2D). Again, the set of gene pairs with such neighborhood
characteristics is enriched with gene pairs that genetically interact
(P=6.26610
2113, hypergeometric test).
Taken together, we showed that our network-based attributes
(CI, N and NPh) of gene pairs are significantly associated with
genetic interactions, suggesting that these attributes may facilitate
the accurate prediction of genetic interactions.
Ultimately, the Exp, Ph, I, CI, N, and NPh attribute values of a
given gene pair are integrated by a logistic regression model that
outputs a prediction score between 0 and 1 representing the
likelihood of a genetic interaction between the two genes (see
Methods).
We performed leave-one-out cross-validation to evaluate the
predictor at different score thresholds (Figure S1). We determined
that a conservative threshold of 0.975 induces error rates
comparable to those achieved by the Zhong and Sternberg (ZS)
genetic interaction predictor (Table S2). However, this threshold
also induces a set of predicted genetic interactions that is 98%
novel when compared to the prediction sets of previous studies
[9,10], and roughly three-fold more genes are present in our set
compared to the ZS set. Thus, under conditions where our
predictor and the ZS predictor have comparable accuracy
estimates, our set of predicted interactions exhibits greater genome
coverage. We chose 0.85 as our definitive threshold since it yields
an estimated false positive rate (Table S2) close to the expected
rate of finding a genetic interaction at random (0.5%) [13],
coinciding with our negative learning set of random gene pairs. At
this threshold, the estimated true positive rate is 10.8% (Table S2).
Although our predictor misses many true positive interactions,
over 800K genetic interactions are predicted and again, 98% of
them are novel (Figure S2A). In particular, our predictor proposes
more interactions per gene on average compared to the ZS
predictor (Figure S2B). In addition, roughly four-fold more genes
are present in our set of predicted interactions compared to the ZS
set (Figure S2B). Thus, when the predictor has an estimated false
positive rate that is appropriately low, the corresponding set of
predicted interactions also exhibits a large increase in genome
coverage compared to the ZS set. Genome-wide genetic
interactions predicted by our method are available online
(http://www.mcb.mcgill.ca/,anna/gInterWorm/search.php).
The biological relevance of the predicted genetic interaction
network was assessed in silico using pathway annotations ([18] and
Table S3). Previous studies show that genetic interactions occur
within and between pathways, although between-pathway inter-
actions are more prevalent amongst interactions identified in
large-scale studies [19–21]. Therefore, we investigated the
connectivity of pairs of genes annotated to the same pathway, in
the predicted network (see Methods). We found that a significant
fraction of these pathway gene pairs are directly connected
(P=10
25, Figure 3A), indicating predicted interactions within
pathways. We also found that a significant fraction of pathway
gene pairs are connected through shared neighbors (P=10
25,
Figure 3B), and in most cases, at least one of the shared neighbors
is not in the same pathway as the pair (98% and 99% of the cases
for all and just signaling pathways, respectively). These cases
indicate predicted interactions that likely occur between pathways,
or within a pathway if the shared neighbor is an unknown member
of the pathway of the pair. Interestingly, we predict significantly
many genetic interactions within and between pathways mapped
from human to C. elegans, as we do for pathways derived directly
from C. elegans (compare ‘‘all pathways’’ to ‘‘signaling pathways’’ in
Figure 3). Taken together, the connectivity of pathway genes in the
predicted network is consistent with connectivity observations
based on genetic interactions identified experimentally [19–21],
even for pathway genes mapped from human, and thus supports
the validity of our predictor.
The set of predicted genetic interactions exhibits
improved coverage of genes conserved between human
and C. elegans
We investigated whether more genes conserved between human
and C. elegans are present in our set of predicted genetic
interactions when compared to other prediction sets. When all
prediction sets are restricted to genes with human orthologues (see
Text S1), it is still true that a large fraction of our set is novel
(Figure S2A). We thus examined the level of characterization of
human genes with C. elegans orthologues present in prediction sets.
Our analysis shows that in silico methods tend to predict genetic
interactions involving well-characterized genes more often than
poorly-characterized genes (Figure S2C). All human genes with C.
elegans orthologues only present in the ZS prediction set have a
high level of characterization (gene characterization index .5
[22]). Interestingly, 25% of human genes with C. elegans
orthologues only present in our prediction set do not have a high
level of characterization. Taken together, our approach predicts a
large number of novel genetic interactions for genes conserved
between C. elegans and human, and also predicts interactions for
genes orthologous to poorly-characterized human genes that have
no predicted interactions by other approaches.
In order to better understand why our method predicts genetic
interactions that are mostly novel, we investigated the genes with
human orthologues associated with mental retardation and synaptic
plasticity (MRSP) that we curated from the literature (Table S4).
Predicting gdi-1 Interactors
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genetic interactions compared to the ZS set (89% and 40% of the
genes, respectively). In examining the MRSP genes that are present
in our set only, we found that these genes are generally associated
with more information with our approach than with the ZS
approach (see Figure S3A and the Methods). In particular, the
additional information comes from our novel network-based
attributes (e.g. the CI and N attributes). The values of these
attributes are computable for nearly all MRSP genes, but the values
of most ZS attributes are computable only for a smaller subset of
the genes (Figure S3B). These results suggest that the network-based
attributes facilitate the prediction of novel interactions.
A large number of human genes associated with disease are
conserved in C. elegans [23]. For example, GDI1,ah u m a ng e n e
associated with mental retardation [5], has high sequence similarity
(Blast E-value: 2.10610
2158)t ogdi-1,aC. elegans gene that has yet to
be functionally characterized. Since GDI1 is involved in neurotrans-
mission and has been associated with cognitive deficiency in human
[5,12], it is functionally related to our set of human MRSP genes
(Table S4). We thus investigated whether the relationship between
GDI1 and MRSP genes is conserved between human and C. elegans.
Interestingly, our method predicts that gdi-1 genetically interacts
more frequently with MRSP genes than with other genes (P=
1.1610
25, two proportion test), and it also shares genetic interaction
partners more frequently with MRSP genes than with other genes
(P=1.1 610
250, two proportion test). These results provide statisti-
cally significant evidence that the interactions between GDI1 and its
potential neurological partners are conserved in C. elegans.
Validation of predicted genetic interactors of gdi-1
We identified phenotypes that result from treating C. elegans
animals with gdi-1(RNAi). These phenotypes include sterility (Ste,
Figure 4C), a gonad morphogenesis defect characterized by a
shortening of gonads (Gon, Figure 4A,C), an ovulation defect
characterized by an accumulation of endomitotic oocytes (Emo,
Figure 4B,C), and a severe reduction of sheath cell contraction
(Figure 4D). We showed that gdi-1 controls ovulation and gonad
morphogenesis processes by modulating somatic gonad cell
functions. That is, rrf-1(pk1417) (WormBase: WBGene00004508)
animals, which are resistant to RNAi in somatic cells, expressed
significantly reduced levels of the phenotypes when subjected to
gdi-1(RNAi) compared to wild-type and mutant animals resistant to
Figure 3. Assessment of the biological relevance of the predicted genetic interaction network with pathway annotations. Here we
show scenarios where a pair of genes annotated to the same pathway (A) is directly connected or (B) shares $1 neighbor in a genetic interaction
network, where the gene pair of interest is highlighted with thick grey rings. In (A), the genes exhibit a within-pathway genetic interaction based on
the given set of pathway annotations. In (B), the genes belonging to the same pathway (e.g. pathway A) both interact with a gene that may either be
an unknown member of the same pathway (within pathway interaction), or may belong to a different pathway (e.g. pathway B, between-pathway
interactions). Below, the frequencies at which each scenario occurs in the predicted network and in randomized networks are shown with respect to
all pathways and to signaling pathways only (see Methods). The ‘‘all pathways’’ and signaling pathway annotations were derived from human and C.
elegans experimental data respectively. For each set of pathway annotations, the median, first and third quartile frequencies of each scenario were
computed across N=100K randomized networks; the bar length depicts the median and the error bars depict the first and third quartiles. Both
scenarios occur more frequently than what is expected by chance, for both sets of pathway annotations.
doi:10.1371/journal.pone.0010624.g003
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Base: WBGene00004508); gdi-1(RNAi) respectively in Figure 4C).
These results suggest that gdi-1 is a critical regulator of signaling
pathways controlling reproductive functions in C. elegans.
To experimentally validate our predictions, we examined 18
strains containing mutations in 12 genes predicted to genetically
interact with gdi-1. Ste, Emo and Gon phenotypes were measured
for mutant and wild-type animals submitted to RNAi against gdi-1
or the negative control, egfp (Figure 5A). Epistasis analyses of these
measurements were performed using three commonly used
statistical models [24,25] to identify significant genetic interactions
(see Tables S5 and S6 for the estimated epistasis coefficients and P
values, respectively). We also applied a statistical test that measures
the suppression of gdi-1(RNAi)-induced phenotypes (see Methods).
Our results show only partial agreement between the different
models of epistasis (Figure 6A). The most stringent requirement
(i.e. significant interaction by all applicable tests, P#0.05) resulted
in a validation success rate of 42%, while more permissive analysis
(i.e. significant interaction by at least one test) increased the success
rate to 67%. This represents an 84- or 134-fold improvement over
the expected success rate from random genetic screening. Although
validation success rates depend on the selected bait gene(s) (e.g. gdi-
1 in our study), our success rates surpass those reported for existing
methods [9,10] (Figure 1A), thus suggesting that our method
represents an important improvement in predictive accuracy.
Of the 12 putative genetic interactions tested, five were successfully
validated according to all statistical tests used to analyse our results.
All five interactions are antagonistic, and the genes that antagonize
gdi-1 are the following: unc-96 (WormBase: WBGene00006825),
encoding a paramyosin-binding protein [26]; unc-89 (WormBase:
WBGene00006820), encoding a titin-like myosin light chain (MLC)-
specific kinase [27]; tra-4 (WormBase: WBGene00018740), a close
orthologue of the human proto-oncoprotein and transcriptional
repressor PLZF (Ensembl: ENSG00000109906) [28]; aspm-1 (Worm-
Base: WBGene00008107), the closest orthologue of the mammalian
ASPM (Ensembl:ENSG00000066279), a gene associated with mitotic
spindle assembly and microcephaly [29,30]; and dyb-1 (WormBase:
WBGene00001115), the closest orthologue of dystrobrevin (Ensembl:
ENSG00000134769), a component of the DGC in human [31].
Notably, we showed genetic interactions between gdi-1 and
regulators of the actin-myosin contractile apparatus. Indeed, gdi-1-
associated phenotypes were reduced by a mutation in the MLC-
specific kinase (MLCK) unc-89,w h i l egdi-1(RNAi) phenocopies a
mutation in the MLC-specific phosphatase mel-11 (WormBase:
WBGene00003196; Figure 5A). This suggests that gdi-1 antagonizes
MLC phosphorylation and consequently, contraction through the
actin-myosin apparatus during gonad morphogenesis. Consistent
with these results, gdi-1-associated phenotypes were reduced by a
chemical inhibitor of MLCK (ML-7) and a chemical inhibitor of
myosin II ATPase activity (blebbistatin) (Figures 5B and 6).
We also identified a genetic interaction between gdi-1 and dyb-1
that affects gonad morphogenesis (Figures 5A and 6). The latter
gene is a close orthologue of dystrobrevin, a component of the
DGC that when altered leads to myopathies [32]. Moreover,
dystrobrevin is a functional partner of dystrophin (Ensembl
ENSG00000198947), a protein that is associated with DMD and
mild cognitive deficiencies in human [32]. C. elegans is a model
organism used to dissect the molecular mechanism of myopathy
associated with mutations in the DGC components dyb-1 and dys-1
(WormBase: WBGene00001131, the orthologue of dystrophin)
[33]. As shown previously, mutations in dyb-1 and dys-1 produce a
progressive myopathy when combined with a weak allele of hlh-1
(WormBase: WBGene00001948; compare panels A and B of
Figure 7) [34,35]. We showed that gdi-1(RNAi) treatment
significantly reduces muscle degeneration in dyb-1(cx36);hlh-
1(cc561) and dys-1(cx18);hlh-1(cc561) mutants (Figure 7C). There-
fore, we demonstrated that the antagonism between gdi-1 and dyb-
1 is conserved in different cellular systems in C. elegans.
Figure 4. Phenotypical characterization of gdi-1(RNAi)-treated
animals. (A,B) DAPI staining of egfp(RNAi)-( l a b e l e dwt)a n dgdi-1(RNAi)-
treated wild-type animals. (A) Gonad morphogenesis defects (Gon)
characterized by short gonads (*) are observed in gdi-1(RNAi)-treated
animals. Scale bar, 200 mm. (B) Accumulation of Endomitotic oocytes (Emo,
arrowheads) in the proximal gonad of gdi-1(RNAi)-treated animals. Arrows
indicate the spermathecae. Scale bar, 25 mm. (C) Sterility (Ste), Gon and
Emo phenotypes were measured in wild-type, rrf-1(pk1417) and ppw-
1(pk2505) animals submitted to gdi-1(RNAi) (N=3). The mean expressivity/
penetrance of each phenotype is shown with error bars representing 6
one standard error. A (*) indicates a statistically significant reduction of the
phenotypes (P#0.05, Student’s t-test) compared to wild-type animals
treated with gdi-1(RNAi).( D) Distributions of the sheath cell contraction
frequency for egfp(RNAi)- (labeled wt)a n dgdi-1(RNAi)-treated animals.
doi:10.1371/journal.pone.0010624.g004
Predicting gdi-1 Interactors
PLoS ONE | www.plosone.org 6 May 2010 | Volume 5 | Issue 5 | e10624Taken together, our experimental results identified genes that
antagonize gdi-1 activity during gonad morphogenesis, ovulation
(Figure 6B), and muscle degeneration.
Discussion
We present a prediction-based approach to identifying
genetic interactions in C. elegans. The approach predicts many
novel interactions, including interactions for poorly-characterized
genes. Our validation results for gdi-1 suggest that our predictions
identify true interactions with a success rate far beyond random
genetic screening (i.e. at least 84-fold greater than the rate of
identifying true interactions by chance), and that our approach has
improved accuracy compared to previous approaches. Moreover,
we identified five genes with antagonistic activities towards gdi-1
activity during gonad morphogenesis and/or ovulation, including
genes associated with phosphorylated MLCs and dyb-1. Interest-
ingly, we also showed that the antagonism between gdi-1 and dyb-1
influences muscle cell morphology.
Our predictor integrates novel attributes based on network
analysis. We showed that each network-based attribute identifies
gene pairs that are enriched for true genetic interactions. The
common interactors (CI) attribute is based on the common PP
interactors of the proteins encoded by the two genes of interest, in
Figure 5. Validation of a subset of genetic interactions predicted for gdi-1. Ste, Gon and Emo phenotypes were measured in animals
submitted to RNAi against egfp (grey) or gdi-1 (green). The mean difference in the expressivity/penetrance of each phenotype in perturbed (mutant
or chemically treated) versus wild-type (wt) animals (denoted w[x]2w[y], for animals of type x and y) is shown with error bars representing 6 one
standard error, N$3. For Ste, the Z-score of the difference in expressivity is plotted (see Text S1). (D) and (*) indicate statistically significantly
differences for animals treated with egfp(RNAi) and gdi-1(RNAi), respectively (P#0.05, see Methods). NA: not available. (A) Differences in phenotype
expressivity induced by mutations in genes predicted to interact with gdi-1. (B) Differences in phenotype expressivity induced by chemical treatment.
Blebbistatin (Blebb.) is a myosin ATPase inhibitor and ML-7 is a specific inhibitor of myosin light-chain kinase.
doi:10.1371/journal.pone.0010624.g005
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have surprisingly many common PP interactors may be members
of the same complex, thereby increasing the likelihood that their
encoding genes genetically interact, since members of the same
complex tend to genetically interact [13,36]. Moreover, the N and
NPh attributes are based on shared phenotypes in a so-called PhEP
network constructed with RNAi knockdown phenotype, gene
expression and PP interaction data. When a specific phenotype is
associated with surprisingly many neighbors of a given gene in the
PhEP network, it may follow that the gene modulates this
phenotype. Thus, if the neighborhoods of two given genes are
characterized by the same phenotype(s), the genes may modulate
the same phenotype(s), thereby increasing the likelihood that they
genetically interact. Furthermore, the network-based attributes
provide additional information for less-studied genes, such as genes
that may not have been assayed individually (e.g. for phenotype
observations) or with other genes systematically (e.g. for PP
interactions). For example, no phenotypes have been observed for
unc-89 and it has not been tested for a PP interaction with gdi-1.
However, the CI and N attributes support a genetic interaction
between unc-89 and gdi-1, which we confirmed experimentally.
This suggests that the network-based attributes facilitate the
accurate prediction of genetic interactions.
Our analyses suggest that in silico approaches tend to predict
genetic interactions involving well-characterized genes more often
than poorly-characterized genes. The Zhong and Sternberg (ZS)
approach explicitly restricts the predictions to genes that satisfy a
minimum information requirement (i.e. a gene must be associated
with information from at least one attribute that is not the C. elegans
gene expression attribute) [10]. Only ,50% of all genes satisfy the
requirement. As a result, only ,25% of all genes pairs are tested in
silico. In our approach, we do not impose a minimum information
requirement. Moreover, we gained information for ,80% of all
gene pairs by integrating our network-based attributes. These
features of our approach may be responsible for the large number
of novel predicted genetic interactions.
All of the experimentally validated interactions are antagonistic.
This suggests that our learning set contains a strong signal for
antagonistic interactions and that our approach captures this
signal. If this is the case, our approach may be advantageous for
predicting antagonistic interactions. Consequently, our approach
may also be advantageous for proposing antagonisms that warrant
further study in mammals towards the identification of therapeutic
targets for monogenic disorders.
Because of its involvement in vesicular trafficking in mammals,
GDI1 may be a critical regulator of several signaling pathways
controlling functions such as synaptic plasticity, learning and
memory acquisition [5,37,38]. Interestingly, the signaling path-
ways involving ephrins, integrins and inositol-triphosphate that
control gonad morphogenesis and ovulation in C. elegans are highly
similar to the pathways controlling synaptic plasticity in human
[39–44]. Supporting this observation, the anti-epileptic drug
valproate, which targets components of these signaling pathways
in human, has been shown to cause severe alteration of sheath cell
contraction and ovulation processes in C. elegans [45]. Moreover,
our data suggest that gdi-1, like valproate [45], controls ovulation
processes by modulating somatic gonad cell functions. As
documented by the Gilbert and Bolker study [46], a conserved
signaling pathway can control different cellular processes in
different organisms; for example, ovulation in C. elegans versus
synaptic plasticity in human. However, a signaling pathway that is
conserved across different cellular systems and species may have
also acquired some context-specific signaling components. We
therefore do not expect all signaling pathway observations in one
context to apply to another context. However, a number of genes
identified as genetic interactors of gdi-1, using Ste, Gon and Emo
as phenotypical readouts in nematodes, have high sequence
similarity to genes with neurological functions in human. These
observations support the search for genetic interactors of gdi-1 with
a role in controlling gonad morphogenesis and ovulation in C.
elegans to suggest likely genetic interactors of GDI1 controlling
cognitive abilities in human. Nevertheless, this strategy for
identifying genetic interactions relevant to cognition requires
extensive validation in higher organisms such as mouse.
One of the genetic interactions that we uncovered is between
gdi-1 and aspm-1. In both C. elegans and mammals, aspm-1 controls
mitotic spindle positioning and consequently, the ratio of
symmetric and asymmetric cell divisions [29,47]. While control
of asymmetric division of somatic gonadal precursor cells (SGPs) is
required for the proper morphogenesis of gonads in C. elegans [48],
it is still unknown whether the modulation of asymmetric division
in these cells is at the origin of the interaction between gdi-1 and
aspm-1. aspm-1 is an orthologue of ASPM, a gene involved with
brain development in human. In particular, ASPM is involved in
the control of neuronal progenitor proliferation and is associated
with microcephaly [47]. Since GDI1 is expressed in both
proliferative and differentiated neurons during brain development
[5], it would be interesting to test whether GDI1 genetically
interacts with ASPM in mammalian brains and consequently, test if
the simultaneous perturbation of both genes would result in a
reduction of cognitive disabilities associated with mutations in
either ASPM or GDI1 alone.
The molecular origin of the genetic interaction observed
between gdi-1 and tra-4 is also unknown. The transcriptional
repressor tra-4 was shown to promote female development by
repressing male-specific genes in C. elegans [28]. This gene was also
characterized as a SynMuvB gene because it was shown to
negatively regulate let-60 (WormBase: WBGene00002335)/Ras-
mediated vulval development in nematodes [28]. Interestingly,
several SynMuvB genes have been shown to control somatic
gonad development [49,50]. Further studies will be required to
assess the function of tra-4 during somatic gonad development and
its potential interaction with SynMuvB genes in the cellular
context of that process.
We also showed genetic interactions between gdi-1 and
regulators of the actin-myosin contractile apparatus. Indeed, gdi-
Figure 6. Epistasis between gdi-1 and its predicted genetic interactors and chemical suppressors. (A) The minimum (M), additive (+) and
multiplicative (*) statistical models of epistasis were used in the analysis. A statistical test for the specific suppression (S) of gdi-1(RNAi)-induced
defects was also used (see Methods for details). Significant synergistic and antagonistic interactions are illustrated with shades of red and blue,
respectively (P#0.05). Darker shades indicate significant interactions with P#0.01. The absence of a statistically significant interaction is indicated by a
white entry. NA: not available. (B) Schematic representation of gdi-1 interactors. Blue lines represent antagonistic interactions with gdi-1. The dashed
red line indicates phenocopy between mel-11 and gdi-1. unc-96 (paramyosin-binding protein), unc-89 [myosin light chain (MLC)-kinase], and mel-11
(MLC-phosphatase) are regulators of the actin-myosin contractile apparatus (AMCA, represented in grey) [26,72]. unc-54 and myo-1 are type II myosin
heavy chains. tra-4 encodes a PLZF-like transcription factor [28]. aspm-1 (orthologue of mammalian ASPM) and dyb-1 (orthologue of a component of
the dystrophin glycoprotein complex, DGC) have been associated with mitotic spindle assembly and DGC function in human, respectively [32]. ML-7
and blebbistatin (Blebb.) are specific inhibitors of MLC-kinase and myosin II ATPase activities, respectively.
doi:10.1371/journal.pone.0010624.g006
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unc-89 and its functional partner unc-96 [26]. Interestingly, unc-96
is required for the proper distribution of unc-89 at the M-line in
body-wall muscle sarcomeres [26]. Our data suggest a partnership
between unc-96 and unc-89 that promotes the contraction of the
actin-myosin contractile apparatus in gonad somatic cells, in a
pathway antagonistic to gdi-1. This hypothesis is also supported by
the significant reduction of gdi-1(RNAi)-induced phenotypes in
animals treated with the MLCK and myosin II inhibitors ML-7
and blebbistatin, respectively.
Interestingly, MLC phosphorylation and myosin II function
have been shown to control synaptogenesis, dendritic spine
morphology and synaptic plasticity in mammals [51,52]. More-
over, the inhibition of MLCK function in the lateral amygdala of
the mouse brain has been shown to enhance auditory fear
conditioning (i.e. learning and memory) and to facilitate synaptic
plasticity [53]. Because mutating GDI1 in mice has the opposite
effect [54], it is of interest to assess whether phosphorylated MLC
and GDI1 have antagonistic functions in neurological mechanisms
that enable learning and memory acquisition in mammals. If
antagonism is present, inhibiting phosphorylated MLC is a
potential therapeutic strategy to reduce the symptoms associated
with GDI1 mutations in human.
We also demonstrated that the activity of gdi-1 is antagonistic with
the activity of the dystrobrevin orthologue, dyb-1, during gonad
morphogenesis in C. elegans. Dystroglycan is another component of
the DGC and its orthologue dgn-1 has been previously shown to
control gonad morphogenesis in C. elegans [55]. Our data suggest
that dyb-1 also contributes to this developmental process. Interest-
ingly, the antagonism between dyb-1 and gdi-1 is consistent with the
likely antagonism in mammals where dystrobrevin acts as a
regulator of cell signaling through the inhibition of receptors and
membrane recycling [56], and GDI1 potentially promotes these
cycling events by regulating RAB4 and RAB5 [38]. We also showed
that this antagonism is conserved in different cellular systems in C.
elegans since gdi-1(RNAi) treatment significantly reduced muscle
degeneration in both dyb-1;hlh-1 and dys-1;hlh-1 animals. Mecha-
nisms of muscle degeneration resulting from functional alterations of
dystrobrevin or dystrophin are still poorly understood in mammals
[57]. While C. elegans is an animal model of choice to dissect the
pathological mechanisms associated with myopathies [58], the
antagonisms observed between the GDI1,d y s t r o b r e v i na n d
dystrophin orthologues in C. elegans should be confirmed in DMD
mammalian models (e.g. the mdx mouse) before considering GDI1
as a promising therapeutic target for DMD. Furthermore, since
DGC components and GDI1 are expressed at the synapses of
hippocampus neurons [34,38] it would be extremely interesting to
test whether perturbations of dystrobrevin function may reduce
cognitive disabilities associated with mutations in GDI1 in mammals.
In summary, we developed a bioinformatics tool to predict
genetic interactions in C. elegans towards the identification of
therapeutic targets to address monogenic disorders associated with
disruptions in signaling homeostasis. Our tool uses network-based
attributes and our validation suggests that it predicts interactions
more comprehensively and with improved accuracy compared to
other tools. In addition, we experimentally confirmed the
interactions that were predicted between gdi-1 and several genes
involved in neurological functions in human. Notably, we
Figure 7. gdi-1 suppresses dys-1-a n ddyb-1-associated muscle
degeneration. Body-wall muscle fibers observed using polarized light
microscopy in (A) wild-type and (B) dys-1(cx18);hlh-1(cc561) animals. The
arrow indicates an abnormal/degenerated muscle cell. Scale bar, 200 mm.
(C) Muscle degeneration was assessed in wild-type (wt), dys-1(cx18);hlh-
1(cc561) and dyb-1(cx36);hlh-1(cc561) animals submitted to RNAi against
egfp (grey) or gdi-1 (green). The percentage of abnormal muscle cells in a
methanol fixed animal, estimated with polarized light microscopy, was
used to quantify muscle degeneration in the animal. Boxplots of these
percentages are shown. The total number of animals assessed across
three independent experiments is shown above each boxplot in
parentheses. The percentage of abnormal muscle cells is significantly
reduced in gdi-1(RNAi)-treated versus egfp(RNAi)-treated mutant animals
as indicated by the P values shown at the top (see Methods).
doi:10.1371/journal.pone.0010624.g007
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dyb-1 reduces the signaling unbalance resulting from a reduction of
gdi-1 expression. We also showed that a reduction of gdi-1
expression significantly reduces muscular dystrophy in nematode
DMD models. Further studies using relevant mammalian models
are required to assess whether ASPM, MLC phosphorylation
machinery and dystrobrevin would be potent therapeutic targets
for cognitive disabilities associated with mutations in GDI1.
Similarly, further studies in mammalian models would be required
to assess whether GDI1 would be a potent therapeutic target for
DMD. In conclusion, we have developed a valuable tool that
facilitates the mapping of genetic interactions in C. elegans. Since
the conservation of pathogenic mechanisms and genetic interac-
tions between distant species is still under intense debate,
experimental validation in mammals of genetic interactions
identified in C. elegans is required to evaluate the potential of our
method to significantly streamline the therapy development
process for monogenic disorders that involve genes and signaling
pathways conserved between human and C. elegans.
Methods
The development and subsequent analysis of the genetic
interaction predictor were completed in the R v2.6 statistical
computing environment (http://www.r-project.org, [59]).
Construction of the learning set
A learning set, comprised of a positive and a negative subset,
was constructed for the training of the predictor of genetic
interactions. The positive learning set consists of 1,522 genetic
interactions identified by automated [60] or manual curation of
the literature (see Table S1). The negative learning set should
consist of pairs of non-interacting genes. Since the vast majority of
gene pairs are believed not to genetically interact [13], we built our
negative learning set from ,14,000 randomly selected gene pairs
from the set of all genes mapped to a genomic location (WormBase
release WS180, http://www.wormbase.org/). The approximate
1:10 ratio of positive to negative interactions was established to
guarantee a learning set with a thorough sampling of all gene pair
combinations (,386 million in total).
Datasets used to derive attributes
The gene expression data was obtained from [14]. We obtained
all RNAi knockdown phenotype data in WormBase release
WS141 and removed seven uninformative or redundant types,
such as ‘‘wildtype’’, ‘‘unclassified’’, ‘‘not embryonic’’ and ‘‘com-
plex phenotype.’’ Protein-protein (PP) interactions were obtained
from all C. elegans, Saccharomyces cervisiae, Drosophila melanogaster, and
Homo sapiens yeast two-hybrid datasets stored in BioGRID v2.0.37
(http://www.thebiogrid.org/) and from two additional yeast two-
hybrid datasets [15,16] that are absent from this database. We
focused on yeast two-hybrid datasets because the technique detects
an interaction with minimal influence from endogenous environ-
ments, e.g. a fly cell. We assume that two proteins do not exhibit a
PP interaction if both proteins were assayed and no interaction
was found. To create a multi-species PP interaction network, we
used the orthology mappings generated by InParanoid v1.35 [17]
(non-default parameters: score cutoff 10, in-paralog confidence
cutoff 0.025, sequence overlap cutoff 0.2) when run with protein
sequences obtained from the InParanoid dataset from June, 2006
(http://inparanoid.sbc.su.se/cgi-bin/index.cgi). Comparisons with
hand-curated orthologies for a subset of genes indicated that our
parameter settings produced orthology mappings with minimal
false positive results (data not shown). The names of the genes/
proteins described in the datasets were updated to the names used
in WormBase release WS180.
Derivation of attributes for use in the logistic regression
The co-expression attribute Exp(g, g9) is the P value derived for
the Pearson correlation of genes g and g9 across all microarray
hybridizations (conditions) relative to the empirically estimated
probability distribution of correlation for all gene pairs (i.e. a fitted
normal). Figure S4 establishes the need for this estimation due to
the lack of fit to standard models of a correlation distribution.
Correlations greater than 0.35 are statistically significant (P#0.05)
according to the estimated distribution. The co-phenotype
attribute Ph(g, g9) measures the statistical significance of the
number of shared phenotypes between the two genes via a
standard Fisher’s exact test (N=the number of phenotypes
observed for at least two genes). We defined the multi-species PP
interaction network such that nodes represent C. elegans proteins
and an edge exists between two proteins if they, or their
orthologous proteins in a species considered here, exhibit a PP
interaction according to the PP interaction dataset. The binary
interaction attribute I(g, g9) indicates whether the proteins encoded
by g and g9 exhibit a PP interaction in our multi-species PP
interaction network (Figure 2A). Similarly, the common inter-
actors attribute, CI(g, g9), considers the statistical significance of the
observed number of common PP interactors of the proteins
encoded by g and g9, in the multi-species PP interaction network
(Figure 2B). Specifically, CI(g, g9) is assigned a P value derived from
a one-tailed Fisher’s exact test (N=the number of genes encoding
proteins that are in the multi-species PP interaction network).
We defined a biological network called the PhEP network,
where two genes g and g9 are connected by an edge if and only if
the Pearson correlation of their gene expression exceeds 0.35, their
gene products exhibit a PP interaction, or their orthologues (in any
species considered here) exhibit a PP interaction (Figure 2C,D).
For a given gene, we measured how surprising it is to witness the
observed number of its neighbors (i.e. genes connected to it by one
edge) in the PhEP network labeled with a specific phenotype
identified by RNAi in C. elegans. This was measured using a one-
tailed Fisher’s exact test (N=the number of genes with some
assigned phenotype). If the derived P value is less than or equal to
0.05 for g and g9 (Figure 2C), we assign a value of 1 to a categorical
variable N(g, g9), and 0 otherwise. Similarly, if g and g9 exhibit a
phenotype that is also enriched in both their neighborhoods in the
PhEP network (Figure 2D), we assigned a value of 1 to a
categorical variable NPh(g, g9), and 0 otherwise.
Missing values for any of the derived attributes (due to missing
values in the underlying datasets) were replaced with the expected
value (i.e. the sample mean) of the attribute before training.
Model specification, training and cross-validation
The logistic regression model is of the form:
ln
p(g,g’)
1{p(g,g’)

~c0zcExpExp(g,g’)
zcPhPh(g,g’)zcII(g,g’)
zcCICI(g,g’)zcNN(g,g’)
zcNPhNPh(g,g’)
where p(g, g9) is the probability of a genetic interaction between
genes g and g9, c0 is the learned intercept term of the model, cExp,
cPh, cI, cCI, cN, cNPh are the learned coefficients for the attributes,
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attribute values for g and g9.
To select the optimal logistic regression model in the context of
our learning set and attributes, we assessed models defined by
different attribute combinations and trained with different
positive:negative weight ratios. Specifically, we trained models
using each of the following weight ratios: 1:1, 1:2, 1:5, 1:10 and
1:100. If negative examples are weighted more heavily, prediction
errors on these examples result in greater penalties, and model
coefficients are fitted accordingly. Using each weight ratio, we
trained the models defined by all non-empty subsets of the
attributes (in total, 2
621=63 models), with each of five different
folds of the learning set to avoid learning set bias. In training each
model with the iterative weighted least squares algorithm [61], we
assume that the initial fit estimated from the weighted data is
reasonably close to the optimal fit, and thus assume that the
algorithm converges to the optimal fit (with the default tolerance
and at most 50 iterations). For each fold, we define the optimal
model as the model that yielded the lowest Akaike’s Information
Criterion (AIC), a measure that considers both fit to the data and
complexity of the model. Any weight ratio that did not yield the
same optimal model for all five folds was eliminated from
consideration. For each remaining weight ratio, we computed
the mean AIC of the optimal model (across the folds). The 1:2
weight ratio yielded the lowest mean AIC and we thus selected this
ratio and the corresponding optimal model to define our genetic
interaction predictor. Therefore, within the scope of logistic
regression models defined by our attributes and trained with our
learning set and tested weight ratios, the full model that uses all six
attributes was found to be optimal based on our convergence
assumptions and the AIC (Table S7).
Leave-one-out cross-validation of the full model was performed to
o b t a i nt r u ea n df a l s ep o s i t i v er a t e sf o r‘ ‘ u n s e e n ’ ’d a t a( F i g u r eS 1 ) .T h e
final predictor was trained on the full learning set using the tuned
weighting and all six attributes. If a pair of genes has a prediction
score $0.85, the two genes are predicted to genetically interact.
Logistic regression is a technique that does not take into account
the obvious dependencies between the attributes. To test the
strength of dependencies between attributes we experimented with
graphical models, specifically by using a software package for
learning Bayesian networks (i.e. the deal package v1.2-30) [62]. The
learning set used to train the logistic model was also used to train a
Bayesian network. The resulting network exhibits several depen-
dencies between the attributes (Figure S5), many of which are
expected since some attributes are derived from the same underlying
datasets. Although predictive accuracy might be improved if these
attribute dependencies were accounted for, doing so would require a
more sophisticated predictive model that relies on an abundance of
data to accurately quantify the dependencies. Due to the paucity of
attribute data for some genes (e.g. a gene may only have data for the
Exp and N attributes), such a predictive model trained with the
current datasets would not necessarily be advantageous over a
simpler model (such as a logistic regression model).
Predictions from other genetic interaction predictors
The functional interactions predicted by the Lee etal. method were
obtained from the WormNet v1 core set [9]. The genetic interactions
predicted by the Zhong and Sternberg method were downloaded in
June, 2006 [10]. The names of the genes in these prediction datasets
were updated to the names used in WormBase release WS180.
Quantifying the information available for a gene
In quantifying the information available for a gene, we took into
account the usefulness of particular types of data for the prediction
of genetic interactions. Specifically, if there is sufficient data to
compute the value of a predictive attribute (e.g. Exp) for any pair
involving a particular gene, the usefulness of the value is quantified
by the magnitude of the weight of the attribute in the predictive
model (e.g. |cExp|). The total quantity of information available for
a gene is thus defined as the sum of the magnitudes of weights
corresponding to attributes for which values can be computed.
The quantities were scaled to be in [0,1] via division by the
maximum quantity achievable. The subsequent relative quantities
allow for comparisons between predictors that use different
attributes (see Figure S3).
Analysis of the predicted genetic interaction network
with pathway annotations
The biological validity of the predicted genetic interaction
network was assessed in silico by computing the shortest path
distance between genes annotated to the same pathway. We
defined the predicted network such that a node exists for each C.
elegans gene and an edge exists between two genes if they are
predicted to genetically interact. We also defined 100K random-
ized networks such that each randomized network is identical to
the predicted network, except that the nodes are assigned a
random permutation of the gene labels. C. elegans pathway
annotations derived from human were obtained from KEGG
release 44 (http://www.genome.jp/kegg/) and signaling pathway
annotations derived directly from C. elegans were obtained from
[63] (Table S3). Using the predicted network and each
randomized network, the shortest path distance (i.e. the minimum
number of edges to traverse in a given network to get from one
gene to the other) was computed for every pairing of genes
annotated to the same pathway. For each network, we
subsequently computed di, the number of pathway gene pairs
with shortest path distance=i, for i=1,2. d1 represents the number
of within-pathway interactions based on the given set of pathway
annotations (Figure 3A). d2 represents the number of pathway gene
pairs that are not connected directly, but share $1 neighbor in the
network, suggesting within- or between-pathway interactions
(Figure 3B). Let di,pred represent di of the predicted network. The
significance of di,pred was estimated with a permutation P
value~(xz1)=(Nz1) [64], where x is the number of randomized
networks with di$di,pred, and N is the total number of randomized
networks. We further examined pathway gene pairs with shortest
path distance=2 in the predicted network. Specifically, we
computed the percentage of these pairs that satisfy the following
criterion: the given pair has $1 shared neighbor that is not
annotated to any of the pathways associated with either member of
the pair. The pairs that satisfy this criterion likely exhibit predicted
within-pathway interactions with an unknown member of the
pathway of the pair, or predicted between-pathway interactions.
Nematode strains
Nematodes were grown on nematode growth media (NGM;
Brenner, 1974) at 20uC. Bristol strain N2 animals were used as wild-
type animals. Nematode strains containing the following alleles were
retrievedfrom the Caenorhabditis Genetic Center (CGC), which isfunded by
the NIH National Center for Research Resources (NCRR): rrf-1
(pk1417),ppw-1 (pk2505),dyb-1 (cx36),unc-89 (e1460),unc-89 (st85),unc-
89 (ok1116), unc-89 (ok1659), unc-96 (su151), tra-4 (ok1636), mel-11
(sb56), trp-2 (gk298) (WormBase: WBGene00006615), smo-1 (ok359)
(WormBase: WBGene00004888), aspm-1 (ok1208), lin-36 (n766)
(WormBase: WBGene00003021), F42G8.10 (ok1199) (WormBase:
WBGene00018361), tag-163 (ok644) (WormBase: WBGene00006508),
F54D5.4 (ok2046) (WormBase: WBGene00010050), dys-1 (cx18), hlh-1
(cc561) (see Table S8).
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Blebbistatin (100 mM) and ML-7 (50 mM) were incorporated in
NGM agar before plate pouring. The drug-containing plates were
used throughout RNAi treatment. The pL4440-dest-gdi-1 con-
struct, used to submit animals to RNAi against gdi-1, was kindly
provided by Dr Marc Vidal, Dana-Farber Cancer Institute. The
pL4440-dest-egfp construct was generated as described previously
[65]. These constructs were transformed into HT115 (DE3) strains
[66] and the animals were submitted to RNAi treatment as
previously described [67]. To score the sterility phenotype (Ste),
synchronized L1 larvae were fed RNAi-expressing bacteria for 72h
at 18uC. Three young adults were then transferred to fresh plates
seeded with RNAi-expressing bacteria and they were allowed to
lay eggs for 48h at 18uC. The progeny were counted and sterility
was measured as detailed in the Epistasis statistics section. The
penetrances of the endomitotic oocyte (Emo) and gonad
morphogenesis defect (Gon) phenotypes were scored after DAPI
staining the RNAi-treated animals fixed with methanol. Emo and
Gon phenotypes were scored by fluorescence microscopy using a
Leica DM5500 microscope equipped with a 636 oil-immersion
objective and using regular sets of filters for excitation at an ultra-
violet wavelength. An animal was considered as expressing the
Emo phenotype if at least one endomitotic oocyte was present in
the gonad. An animal was considered as expressing the Gon
phenotype if its gonad was significantly shorter than gonads
observed in N2 animals. The position of the gonad turn with
respect to the anterior and posterior intestine nuclei was used to
measure the relative length of a gonad. Muscle degeneration was
observed in methanol-fixed nematodes upon polarized-light
illumination, using a Leica DM5500 microscope equipped with
a 1006 oil-immersion objective. Only the centermost 20 cells of
the two muscle quadrants facing the objective were observed to
quantify the abnormal cells. Fluorescent microscopy pictures were
captured using the Leica DFC350FX R2 camera and the Leica
AF6000 software series. Polarized light microscopy pictures were
captured from a Zeiss Axioimager Z1 equipped with a 636 oil-
immersion objective and an Axiocam HRM camera controlled by
the Axiovision software v4.5. The potential modulation of RNAi
efficiency in the different backgrounds tested, and the relative
contribution of balancers to identified genetic interactions, were
examined to confirm the validity of our results (see Text S1 and
Figure S6).
Measurement of sheath cell contraction
Sheath cell contraction rates were scored in anesthetized
animals (0.1% tricaine and 0.01% tetramisole in M9 buffer) as
previously described [68]. Basal contractions were estimated by
monitoring lateral sheath displacement [69] upon DIC illumina-
tion at room temperature, using a Leica DM5500 microscope
equipped with a 636oil-immersion objective.
Epistasis statistics
Let wx M [0,1] represent the level of a particular phenotype
expressed by genetic population x. Conversely, let Fx~1{wx
represent the ‘‘fitness’’ of x with respect to the phenotype, e.g. a
maximal value of 1 indicates that the phenotypic defects are
absent in all animals of type x.L e twm, wgdi-1, wm/gdi-1 and wwt
represent the level of the phenotype expressed by animals with
mutation(s) in (predicted interactor) gene m, wild-type animals
submitted to gdi-1(RNAi), m-mutant animals submitted to gdi-
1(RNAi) and wild-type animals, respectively. Three different
models were used to quantify epistatic effects through an epistasis
coefficient e. The models use values that have been normalized to
wild-type levels, i.e. w’ x~wx{wwt and F’ x~Fx=Fwt. Under the
minimum model [70]:
e~(Fm=gdi{1{Fwt){min(Fm{Fwt,Fgdi{1{Fwt)
~max(w’ m,w’ gdi{1){w’ m=gdi{1
Under the additive model [25]:
e~(w’ mzw’ gdi{1){w’ m=gdi{1
Under the multiplicative model [25]:
e~F’ m=gdi{1{F’ m:F’ gdi{1
Within each model, a function of the phenotypic level expressed by
the doubly-altered population (e.g. wm/gdi-1) is compared to some
expectation of the level, given what is known about the populations
with the single-gene perturbations. This expectation is computed
by a model-specific function, f(wm, wgdi-1, wwt) M [0,1]. For example,
under the additive model, f(wm,wgdi{1,wwt)~w’ mzw’ gdi{1 if
w’ mzw’ gdi{1ƒ1, otherwise f(wm,wgid{1,wwt)~1.
If e,0, there is a synergistic interaction between m and gdi-1.I f
e.0, there is an antagonistic interaction. We also identified genes
that, when mutated, specifically suppress the phenotypic effects of
gdi-1(RNAi) (observed in wild-type animals). This was achieved by
statistically testing if w’ gdi{1{w’ m=gdi{1w0. See Text S1 for details
regarding all statistical tests performed, including details about our
normality assumption (Figure S7).
The Ste level expressed by a genetic population x was defined as
wx~1{Bx=Bwt, where Bx and Bwt are the brood size measure-
ments for x and wild-type animals, respectively. The Gon and Emo
levels were defined as wx~nx=nx,total, where nx is the number of x
animals observed to have the phenotype and nx,total is the total
number of x animals examined.
Statistic for the suppression of muscle degeneration
Let wx~yx=nx represent the level of muscle degeneration
expressed by an animal in genetic population x,w h e r eyx is the
number of abnormal muscle cells and nx is the total number of
muscle cells observed in the animal. In each independent
experiment, at least 20 animals were observed for each
genetic population. We statistically tested the hypothesis that
wm/gdi-1,wm,i . e .gdi-1(RNAi) treatment suppresses the muscle
degeneration observed in m-mutant animals. Specifically, the
hypothesis was tested using the Mann-Whitney test and a P
value was obtained for each independent experiment. The P
values were combined to compute an overall P value using the
weighted-Z method [71] (N=3). The weight of each indepen-
dent experiment was the total number of animals observed
(i.e. the number of gdi-1(RNAi) treated m-mutant animals
observed plus the number of control-treated m-mutant animals
observed).
Supporting Information
Text S1 Supporting Methods.
Found at: doi:10.1371/journal.pone.0010624.s001 (0.05 MB
DOC)
Figure S1 Receiver-operating-characteristic curve of the genetic
interaction predictor. The error rates were estimated with leave-
one-out cross-validation. The threshold associated with each point
(i.e. a pair of rates) is indicated in red text. Only the portion of the
curve with the smallest false positive rates is shown since, in
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more important for laborious experimental validation.
Found at: doi:10.1371/journal.pone.0010624.s002 (0.08 MB
TIF)
Figure S2 Comparison of genome-wide genetic interactions
predicted by different approaches. (A) Venn diagrams of
predicted interactions from Zhong and Sternberg [10], Lee
et al. [9] and this study. Left, interactions between any C. elegans
genes. Right, interactions between C. elegans genes with human
orthologues. Our approach predicts many novel interactions and
about 85% of them are between C. elegans genes without human
orthologues. (B) Comparison of the mean number of predicted
interactions per gene and the percentage of genes with predicted
interactions (i.e. the percentage of the genome covered by the set
of predicted interactions), between two studies. The comparisons
are made in the context of mental retardation and synaptic
plasticity (MRSP) genes only and in the genome-wide context
(GW). (C) Comparison of the number of human genes whose C.
elegans orthologues have predicted interactions, stratified by gene
characterization index (see Text S1). Our approach predicts
novel interactions for genes orthologous to poorly-characterized
human genes.
Found at: doi:10.1371/journal.pone.0010624.s003 (0.42 MB
TIF)
Figure S3 The relationship between the quantity of information
available for a gene and the number of predicted genetic
interactions. The quantity of information available for a gene is
a measure that takes into account the fact that some gene pair
attributes are more informative than others for predicting genetic
interactions. See the Methods for the computation of the total
quantity of information for each gene. MRSP: mental retardation
and synaptic plasticity; ZS: Zhong and Sternberg [10]. (A) The
total quantity of information available for MRSP genes with the
ZS approach and with our approach. The three sets of boxplots
correspond to MRSP genes with predicted interactions in this
study only, in the ZS study only and in neither study, respectively.
(B) Types and total quantity of information available for MRSP
genes with the ZS approach and with our approach. Each column
corresponds to a gene and a black entry indicates that there is
information for the gene of the type specified (to the left) by the
row (except for the row labeled ‘‘Total quantity of information’’).
The ZS approach separates the information from three organisms:
Saccharomyces cerevisiae (Sc), Drosophila melanogaster (Dm) and Caenor-
habditis elegans (Ce). The information types (i.e. attributes) of this
study are described in the Results and Methods. For each
approach, there is also a row indicating the total quantity of
information (scaled between 0 and 1), where white and black
indicate zero and maximal information, respectively. The
heatmap in the middle illustrates the number of interactions
predicted for each gene by the different approaches, where a
greater intensity of red corresponds to a greater number. gdi-1 is
highlighted in green.
Found at: doi:10.1371/journal.pone.0010624.s004 (1.22 MB
TIF)
Figure S4 Different methods for estimating the P value
associated with a Pearson correlation value measuring the
coexpression of two genes in the Kim et al. dataset [14]. The
grey bars indicate the empirical P values associated with bins of
correlation values. The t-distribution (blue line) and Fisher’s Z
transform (red line) methods do not produce P values that match
the empirical trend closely. In contrast, the fitted normal
distribution approximates the empirical distribution well (green
line).
Found at: doi:10.1371/journal.pone.0010624.s005 (0.14 MB TIF)
Figure S5 The dependencies between the predictive gene pair
attributes as defined by a learned Bayesian network. See the
Methods for how the Bayesian network was derived.
Found at: doi:10.1371/journal.pone.0010624.s006 (0.13 MB
TIF)
Figure S6 The interaction of gdi-1 with unbalanced heterozygotes
of aspm-1(ok1208). The mean penetrance/expressivity of the Emo
phenotype in wild-type (wt) or unbalanced aspm-1(ok1208) hetero-
zygotes (aspm-1(ok1208) +/2), submitted to either egfp or gdi-1
RNAi, is shown. The error bars correspond to 6 one standard
error over three independent experiments. (*) indicates a statistical
difference between wt and aspm-1(ok1208) +/2 animals submitted
to gdi-1(RNAi) (P#0.05, see Methods).
Found at: doi:10.1371/journal.pone.0010624.s007 (0.08 MB
TIF)
Figure S7 Validity of the normality assumption for the
application of Student’s t-tests to phenotype measurement data.
The bars represent the empirical distribution of scaled phenotype
values induced by gdi-1(RNAi) treatment (see Text S1). Each red
line is a fitted normal distribution.
Found at: doi:10.1371/journal.pone.0010624.s008 (0.11 MB
TIF)
Table S1 Genetic interactions hand-curated from the literature.
Found at: doi:10.1371/journal.pone.0010624.s009 (0.05 MB
XLS)
Table S2 Performance of genetic interaction predictors.
Found at: doi:10.1371/journal.pone.0010624.s010 (0.02 MB
XLS)
Table S3 Signaling pathway genes curated from the C. elegans
literature.
Found at: doi:10.1371/journal.pone.0010624.s011 (0.05 MB
XLS)
Table S4 Curated set of mental retardation and synaptic
plasticity genes and their C. elegans orthologues (204 genes).
Found at: doi:10.1371/journal.pone.0010624.s012 (0.04 MB
XLS)
Table S5 Epistasis coefficients of experimentally tested genetic
interactions.
Found at: doi:10.1371/journal.pone.0010624.s013 (0.03 MB
XLS)
Table S6 Epistasis P values of experimentally tested genetic
interactions.
Found at: doi:10.1371/journal.pone.0010624.s014 (0.02 MB
XLS)
Table S7 AIC values of 63 logistic regression models that use
different combinations of the gene pair attributes.
Found at: doi:10.1371/journal.pone.0010624.s015 (0.03 MB
XLS)
Table S8 Genotypes of C. elegans strains used in this study.
Found at: doi:10.1371/journal.pone.0010624.s016 (0.02 MB
XLS)
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